With the COVID-19 Public Health Emergency now set to stretch into at least early 2021, labs and pathologists performing this testing have had to adapt to constantly shifting rules in order to both get paid and remain compliant. Not only are providers working to properly bill for their services when performing testing for workplace screening, but they also must now prepare for a reduced Medicare payment for this crucial service beginning Jan. 1, 2021.
During this session Vachette CEO Mick Raich, along with VP of Client Services Ann Lambrix and VP of Sales and Marketing Dustin Suntheimer, addressed these questions and a host of other COVID-19 billing and compliance issues. Topics discussed include:
Understanding the latest rules and regulations for COVID-19 testing and billing:
–When can providers bill the Uninsured Patient Portal?
–Does employee testing (workplace screening) comply with medical necessity requirements?
–How is this affected by CMS’s one-test rule without a practitioner’s order?
–Who should be billed in these scenarios?
–What about pre-admission screening?
–Commercial payers, are they required to reimburse?
–Establishing client bill arrangements that comply with state and federal regulations.
Examining the COVID-19 payment reduction and new add-on code for timely turnarounds:
–How should U0005 be properly utilized to receive the $25 add-on payment?
–How your COVID-19 turnaround times for all payers will impact your Medicare payments.
Reviewing respiratory panel billing restrictions at the MAC level:
–MACs restricting the total number of targets as utilization of these panels increases.
–Why you shouldn’t undercode to get paid.
–Independent labs now eligible to bill these panels.
Updates on government relief funds and repayment requirements:
–HHS Provider Relief